The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
As long as Tata Sons cannot deregister itself as NBFC, the listing criteria of RBIs NBFCs in the Upper Layer (NBFC-UL) rule will hang on the company. If it does manage to deregister, then it can avoid ...
HM Electro Mech's SME IPO opens today and aims to raise Rs 28 crore through the issue of 36.99 lakh shares priced between Rs 71-75 each. The IPO closes on January 28, with shares expected to list on ...
Results that may be inaccessible to you are currently showing.